Survival in HIV+ and HIV− women with breast cancer treated at the National Cancer Institute in the city of Rio de Janeiro, Brazil, between 2000 and 2014 by Mariana Pinto Ferreira, Luiz Claudio Santos Thuler, Marcelo A. Soares, Esmeralda A. Soares, Anke Bergmann

Get full text

Rotina de treinamento laboratorial em microcirurgia do Instituto Nacional do Câncer Laboratory training program in microsurgery at the National Cancer Institute by Diogo Almeida Lima, Mário Sérgio Lomba Galvão, Marcelo Moreira Cardoso, Paulo Roberto de Albuquerque Leal

“…The present study describes the microsurgery training program of the Laboratory of Experimental Microsurgery of the National Cancer Institute (Rio de Janeiro, RJ, Brazil).…”
Get full text

Gender Differences in X (Formerly Twitter) Use Among Oncology Physicians at National Cancer Institute–Designated Cancer Centers: Cross-Sectional Study by Vivian Tieu, Sungjin Kim, Minji Seok, Leslie Ballas, Mitchell Kamrava, Katelyn M Atkins

Get full text

Phase 0 Radiopharmaceutical–Agent Clinical Development by Charles A. Kunos, Larry V. Rubinstein, Jacek Capala, Michael A. McDonald

Subjects: Get full text

The effect of consuming voluntarily fortified food and beverages on usual nutrient intakes in the Canadian population by Valerie Tarasuk, Didier Brassard

Subjects: Get full text

Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™) by Evalien Veldhuijzen, Iris Walraven, Sandra A. Mitchell, Elizabeth Yohe Moore, Shawn M. McKown, Matthew Lauritzen, Katherine J. Kim, José S. A. Belderbos, Neil K. Aaronson

“…Abstract Background The U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™) is a library of items for assessing symptomatic adverse events by patient self-report in oncology trials. …”
Get full text

Recommendations from a Dialogue on Evolving National Cancer Institute-Designated Comprehensive Cancer Center Community Outreach and Engagement Requirements: A Path Forward

“…To help address inequities in cancer treatment, care, support and research, the National Cancer Institute (NCI) instituted the community outreach and engagement (COE) mandate for NCI-designated comprehensive cancer centers (CCCs). …”
Get full text

Survey of Lifestyle, Past Medical History and Complementary and Alternative Medicine Use Among Adult Patients Participating in the National Cancer Institute's Exceptional Responders Initiative by Oluwadamilola Olaku, Barbara A. Conley, S. Percy Ivy, Lisa M. McShane, Louis M. Staudt, Sophie M. King, Megan Sansevere, Benjamin Kim, Jeffrey D. White

“…Introduction: The Exceptional Responders Initiative (ERI) at the National Cancer Institute attempts to correlate unusually good outcomes in patients with cancer with genetic targets in tumors and the therapies the patients received. …”
Get full text

Comparison and optimization of deep learning-based radiosensitivity prediction models using gene expression profiling in National Cancer Institute-60 cancer cell line by Euidam Kim, Yoonsun Chung

“…Methods: The clonogenic surviving fractions at 2 Gy from previous publications and microarray gene-expression data from the National Cancer Institute-60 cell lines were used to measure the radiosensitivity. …”
Get full text

Genetic polymorphisms of the <it>GNRH1 </it>and <it>GNRHR </it>genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3) by Lund Eiliv, Lenner Per, Isaacs Claudine, Hunter David J, Hoover Robert, Hankinson Susan E, Haiman Christopher A, Feigelson Heather, Dossus Laure, Clavel-Chapelon Francoise, Chanock Stephen, Calle Eugenia E, Buring Julie, Boeing Heiner, Bingham Sheila, Berg Christine, Henderson Brian E, Henderson Katherine D, Cox David G, Kaaks Rudolf, Canzian Federico, Overvad Kim, Palli Domenico, Pearce Celeste, Quiros Jose R, Riboli Elio, Stram Daniel O, Thomas Gilles, Thun Michael J, Trichopoulos Dimitrios, van Gils Carla H, Ziegler Regina G

“…We studied the association between breast cancer risk and polymorphisms in genes that code for GNRH1 and its receptor (GNRHR) in the large National Cancer Institute Breast and Prostate Cancer Cohort Consortium (NCI-BPC3).…”
Get full text

Making National Cancer Institute–Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study by Maitri Kalra, Elizabeth Henry, Kelly McCann, Meghan S Karuturi, Jean G Bustamante Alvarez, Amanda Parkes, Robert Wesolowski, Mei Wei, Sarah S Mougalian, Gregory Durm, Angel Qin, Caitlin Schonewolf, Meghna Trivedi, Avan J Armaghani, Frederick H Wilson, Wade T Iams, Anita A Turk, Praveen Vikas, Michael Cecchini, Sam Lubner, Priyadarshini Pathak, Kristen Spencer, Vadim S Koshkin, Matthew K Labriola, Catherine H Marshall, Katy E Beckermann, Marina N Sharifi, Anthony C Bejjani, Varsha Hotchandani, Samir Housri, Nadine Housri

“…ObjectiveUsing an oncologist-only question and answer (Q&A) website, we sought to document expert insights from TBs at National Cancer Institute–designated Comprehensive Cancer Centers (NCI-CCCs) to provide educational benefits to the oncology community. …”
Get full text

NASH and cryptogenic cirrhosis: A histological analysis†† Financial Support/Grants: This research supported in part by the Intramural Research Program of the NIH, National Cancer Institute. by Stephen H. Caldwell, Vanessa D. Lee, David E. Kleiner, Abdullah M.S. Al-Osaimi, Curtis K. Argo, Patrick G. Northup, Carl L. Berg

Get full text

Japanese translation and linguistic validation of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) by Tempei Miyaji, Yukiko Iioka, Yujiro Kuroda, Daigo Yamamoto, Satoru Iwase, Yasushi Goto, Masahiro Tsuboi, Hiroki Odagiri, Yu Tsubota, Takashi Kawaguchi, Naoko Sakata, Ethan Basch, Takuhiro Yamaguchi

“…Abstract Background The US National Cancer Institute (NCI) has developed the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) to capture patients’ self-reported symptomatic adverse events in cancer clinical trials. …”
Get full text

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). by Setiawan, V, Schumacher, F, Haiman, C, Stram, DO, Albanes, D, Altshuler, D, Berglund, G, Buring, J, Calle, E, Clavel-Chapelon, F, Cox, D, Gaziano, J, Hankinson, SE, Hayes, R, Henderson, B, Hirschhorn, J, Hoover, R, Hunter, D, Kaaks, R, Kolonel, L, Kraft, P, Ma, J, Le Marchand, L, Linseisen, J, Lund, E

Pediatric effective dose assessment for routine computed tomography examinations in Tehran, Iran by Atefeh Tahmasebzadeh, Asghar Maziyar, Reza Reiazi, Mojtaba Soltani Kermanshahi, Seyyed Hossein Mousavie Anijdan, Reza Paydar

Subjects: Get full text

ORGANIZAÇÃO E DESEMPENHO: AVALIAÇÃO DA CENTRALIZAÇÃO DA PATOLOGIA DO INCA-BRASIL by Marcelino José Jorge, Frederico A. de Carvalho, Rafael Pessoa Santiago, Daniela de Souza

Subjects: Get full text

Extending import detection algorithms for concept import from two to three biomedical terminologies by Vipina K. Keloth, James Geller, Yan Chen, Julia Xu

Subjects: Get full text

Reported use of reporting guidelines among JNCI: Journal of the National Cancer Institute authors, editorial outcomes, and reviewer ratings related to adherence to guidelines and clarity of presentation by Jeannine Botos

“…Abstract Background Associations were examined between author-reported uses of reporting guidelines to prepare JNCI: Journal of the National Cancer Institute (JNCI) submissions, editorial decisions, and reviewer ratings for adherence to reporting guidelines and clarity of presentation. …”
Get full text

How vision and leadership shaped the U.S. National Cancer Institute's 50-year journey to advance the evidence base of cancer control and cancer care delivery research by Arnold D. Kaluzny, Donna M. O'Brien

“…In 1971, Congress passed the National Cancer Act, landmark legislation that reorganized the National Institutes of Health's National Cancer Institute (NCI). The Act included a new focus on cancer control, including the requirement that the NCI award research grants and contracts, in collaboration with other public agencies and private industry, to conduct cancer control activities related to the diagnosis, prevention, and treatment of cancer. …”
Get full text

Surgical, oncologic, and obstetric outcomes of radical trachelectomy in early-stage cervical cancer: results from a retrospective cohort study at Brazil National Cancer Institute by José Augusto Bellotti, José Augusto Bellotti, Isabella Gonçalves Gutierres, Isabella Gonçalves Gutierres, Yara Lúcia Furtado, Yara Lúcia Furtado, Patricia Patury, Juliana de Almeida Figueiredo, Gustavo Guitmann, Rossano Keppler Alvin Fiorelli, Fernanda Campos da Silva

“…Objectiveto analyze oncological, obstetrical, and surgical results of young early-stage cervical cancer patients who underwent radical trachelectomy (RT) surgery and wished to maintain their fertility.Methodologya retrospective cohort study was carried out concerning cases attended at the Brazilian National Cancer Institute Gynecology Oncology Service. Patients who underwent RT between January 2005 and January 2021 were included.ResultsA total of 32 patients with median age of 32 years old, 62.5% of whom were nulliparous, were assessed. …”
Get full text